Wegovy & Zepbound GLP-1 Solutions for Weight Loss

Keep on believing, because it's not just about the weight you lose, it's about everything you gain

Membership is only $125/mo includes doctor's visit and the cost of lab test by Quest Diagnostics. Medication delivered to your home directly from the pharmacutucal company. Cost of medication is not included in membership.

Three months minium membership paid monthly

Transparent Medication Pricing

Wegovy Pen

Starting at
$199 / Month
Wegovy Pill

Starting at
$149 / month
Zepbound Pre-Filled Single Dose Pen
Insurance as low as $25 / Month
Zepbound
Single Dose Vial
Starting at $299 / month cash pay

Zepbound®

Zepbound® is an injectable prescription medication that may help adults with:
  • Obesity, or some adults with overweight who also have weight related medical problems to lose excess weight body weight and keep the weight off.
  • Moderate to severe obstructive sleep apnea (OSA) and obesity to improve their OSA
It should be used with a reduced-calorie diet and increased physical activity.

Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children. Expected weight loss is 22.5% of body weight.

Wegovy®

WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults with obesity (BMI ≥30 for adults, or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems to help them lose weight and keep it off.

Wegovy should be used with a reduced calorie meal plan and increased physical activity.

Wegovy contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicine.

It is not known if Wegovy is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if Wegovy can be used safely in people with a history of pancreatitis.

Expected weight loss is 16.9% of body weight.

Reproductive Considerations

  • Women who plan to become pregnant should not take weight loss medications.
  • Taking weight loss medications at the time of conception can cause harm to the developing child.
  • Weight loss medications should be discontinued at lease 2 months prior to attempting to become pregnant.
  • Contraception should be used for the entire duration of therapy and continued for two months once therapy ends.
  • We recommend pregnancy testing prior to beginning therapy with weight loss medications.
  • Women of child bearing age should monitor their menstrual cycles closely and perform regular pregnancy testing with your primary care provider or gynecologist.